Surging coronavirus cases throughout the United States are triggering delays in acquiring check final results from laboratories, according to Quest Diagnostics, a foremost provider of diagnostic companies.
“Soaring demand” for a Covid-19 molecular take a look at is “slowing the time” the business can present test results even immediately after fast scaling up its potential, Quest claimed Monday.
Amplified capacity: The company has previously doubled its tests capability from two months ago, and now is able to conduct 125,000 molecular diagnostic exams a day. By the stop of the thirty day period, it expects to have the capability for 150,000 checks a day.
Irrespective of this increase in potential, it truly is taking up to a working day to method examination final results for its precedence sufferers: hospital clients, pre-operative sufferers in acute treatment configurations and symptomatic health care employees. For all other conditions, it is having on common seven or far more times, mentioned Quest in a press launch.
The firm is struggling with difficulties in making an attempt to ramp up screening: World wide source constraints are nonetheless an difficulty, the firm reported.
The lab community is attempting to incorporate new technology platforms and is looking at an expansion of its lab referral plan.
But the company cautioned that it cannot lower its turnaround time on tests benefits as lengthy as Covid-19 scenarios carry on spiking throughout the place.
“This is not just a Quest challenge. The surge in Covid-19 conditions impacts the laboratory sector as a total,” the firm stated.